Speaker illustration

Doctor Nobutoyo Masunaga

Kyoto Medical Centre, Kyoto (Japan)

Member of:

European Society of Cardiology

Year-to-year change of antithrombotic strategy and clinical outcomes of atrial fibrillation patients with vascular disease in this decade: The Fushimi AF Registry.

Event: ESC Congress 2023

Topic: Clinical

Session: From mobile health technology to clinical issues in atrial fibrillation

Thumbnail

The association of left ventricular ejection fraction with incident heart failure in patients with atrial fibrillation

Event: ESC Congress 2022

Topic: Heart Failure in Atrial Fibrillation

Session: Interplay between heart failure and atrial fibrillation

Thumbnail

Clinical characteristics and outcomes of atrial fibrillation patients with peripheral artery disease: The Fushimi AF Registry.

Event: ESC Congress 2022

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Atrial fibrillation and concomitant medical conditions

Thumbnail

Comparison of characteristics and outcomes of atrial fibrillation patients undergoing coronary artery bypass grafting surgery and percutaneous coronary intervention: From the Fushimi AF Registry.

Event: ESC Congress 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment

Thumbnail

The clinical outcomes in atrial fibrillation patients with vascular disease: the Fushimi AF Registry.

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Miscellaneous in arrhythmia

Thumbnail

The combination therapy with oral anticoagulant and antiplatelet drug for atrial fibrillation patients: the Fushimi AF Registry.

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation II

Thumbnail

ESC 365 is supported by